Cheaper avastin copycat tested in healthy volunteers
Knowledge-focused
Completed
This study tested a new biosimilar drug called HD204 against the original Avastin in 119 healthy men. The goal was to see if the body processes both drugs the same way. Participants received a single dose, and researchers measured drug levels and safety. The trial is complete, bu…
Phase: PHASE1 • Sponsor: Prestige Biopharma Limited • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC